Brian F. Thomas

7.2k total citations · 1 hit paper
134 papers, 5.7k citations indexed

About

Brian F. Thomas is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Brian F. Thomas has authored 134 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pharmacology, 61 papers in Cellular and Molecular Neuroscience and 32 papers in Molecular Biology. Recurrent topics in Brian F. Thomas's work include Cannabis and Cannabinoid Research (76 papers), Neurotransmitter Receptor Influence on Behavior (49 papers) and Forensic Toxicology and Drug Analysis (28 papers). Brian F. Thomas is often cited by papers focused on Cannabis and Cannabinoid Research (76 papers), Neurotransmitter Receptor Influence on Behavior (49 papers) and Forensic Toxicology and Drug Analysis (28 papers). Brian F. Thomas collaborates with scholars based in United States, United Kingdom and Australia. Brian F. Thomas's co-authors include Jenny L. Wiley, Billy R. Martin, Julie A. Marusich, David M. Compton, Yanan Zhang, Herbert H. Seltzman, Megan Grabenauer, Timothy W. Lefever, Anne F. Gilliam and Raj K. Razdan and has published in prestigious journals such as JAMA, Analytical Chemistry and American Journal of Clinical Nutrition.

In The Last Decade

Brian F. Thomas

132 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Labeling Accuracy of Cannabidiol Extracts Sold Online

2017 358 citations Marcel O. Bonn‐Miller, Brian F. Thomas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian F. Thomas United States	39	3.0k	2.1k	1.2k	1.1k	669	134	5.7k
Simona Pichini Italy	50	2.3k 0.8×	1.2k 0.5×	3.1k 2.6×	1.3k 1.1×	818 1.2×	348	9.1k
Kazuhito Watanabe Japan	34	2.7k 0.9×	862 0.4×	468 0.4×	652 0.6×	584 0.9×	218	4.6k
Edward J. Cone United States	62	3.7k 1.2×	2.6k 1.2×	5.1k 4.2×	1.8k 1.6×	1.1k 1.7×	268	11.7k
Marilyn A. Huestis United States	56	5.4k 1.8×	1.8k 0.9×	4.9k 4.0×	1.4k 1.2×	1.6k 2.4×	213	11.1k
Rudolf Brenneisen Switzerland	40	2.0k 0.7×	1.8k 0.8×	2.1k 1.7×	541 0.5×	409 0.6×	112	5.8k
Justin L. Poklis United States	37	1.4k 0.5×	1.3k 0.6×	1.2k 1.0×	840 0.7×	222 0.3×	144	3.8k
Francesco Paolo Busardò Italy	40	1.7k 0.6×	883 0.4×	2.5k 2.0×	816 0.7×	588 0.9×	230	5.2k
Frank Mußhoff Germany	42	1.2k 0.4×	658 0.3×	2.9k 2.4×	1.2k 1.0×	991 1.5×	240	6.5k
Sumner Burstein United States	44	3.9k 1.3×	1.5k 0.7×	606 0.5×	1.1k 1.0×	593 0.9×	131	5.5k
Peter Jatlow United States	48	1.1k 0.4×	2.1k 1.0×	900 0.7×	1.5k 1.4×	318 0.5×	161	6.6k

Countries citing papers authored by Brian F. Thomas

Since Specialization

Citations

This map shows the geographic impact of Brian F. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian F. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian F. Thomas more than expected).

Fields of papers citing papers by Brian F. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian F. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian F. Thomas. The network helps show where Brian F. Thomas may publish in the future.

Co-authorship network of co-authors of Brian F. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Brian F. Thomas. A scholar is included among the top collaborators of Brian F. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian F. Thomas. Brian F. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Brian F., et al.. (2020). Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs. Cannabis and Cannabinoid Research. 5(4). 340–343. 6 indexed citations

Wiley, Jenny L., Timothy W. Lefever, Michelle Glass, & Brian F. Thomas. (2019). Do you feel it now? Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice. NeuroToxicology. 73. 161–167. 18 indexed citations

Gamage, Thomas F., Charlotte E. Farquhar, Timothy W. Lefever, et al.. (2017). The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB 1 receptor allosteric modulators. Neuropharmacology. 125. 365–375. 21 indexed citations

Thomas, Brian F. & Gerald T. Pollard. (2016). Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States. Frontiers in Pharmacology. 7. 285–285. 21 indexed citations

Perrey, David A., Ann M. Decker, Jun‐Xu Li, et al.. (2015). The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Bioorganic & Medicinal Chemistry. 23(17). 5709–5724. 16 indexed citations

Wiley, Jenny L., Julie A. Marusich, Brian F. Thomas, & Kia J. Jackson. (2014). Determination of Behaviorally Effective Tobacco Constituent Doses in Rats. Nicotine & Tobacco Research. 17(3). 368–371. 17 indexed citations

Murineddu, Gabriele, Battistina Asproni, Stefania Ruiu, et al.. (2012). Tricyclic Pyrazoles. Part 5. Novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 Ligands Using Molecular Hybridization Based on Scaffold Hopping. PubMed. 6(1). 1–14. 17 indexed citations

Hatsukami, D. K., Stephen J. Heishman, Rachel I. Vogel, et al.. (2012). Dose-Response Effects of Spectrum Research Cigarettes. Nicotine & Tobacco Research. 15(6). 1113–1121. 66 indexed citations

Bauer, Kenneth S., Alexander Zakharov, Judith M. Hill, et al.. (2009). Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes. Chemico-Biological Interactions. 183(2). 317–326. 6 indexed citations

10.

Rees, Vaughan W., et al.. (2007). Physical design analysis and mainstream smoke constituent yields of the new potential reduced exposure product, Marlboro UltraSmooth. Nicotine & Tobacco Research. 9(11). 1197–1206. 17 indexed citations

11.

Roy, Sucharita, Jenny L. Wiley, Billy R. Martin, et al.. (2007). Novel, potent THC/anandamide (hybrid) analogs. Bioorganic & Medicinal Chemistry. 15(24). 7850–7864. 12 indexed citations

12.

Beardsley, Patrick M. & Brian F. Thomas. (2005). Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behavioural Pharmacology. 16(5-6). 275–296. 36 indexed citations

13.

Varvel, Stephen A., et al.. (2005). Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice. Journal of Pharmacology and Experimental Therapeutics. 314(1). 329–337. 103 indexed citations

14.

Fischer, Leslie M., A. Robert Jeffcoat, Matthew Koch, et al.. (2004). Clinical Characteristics and Pharmacokinetics of Purified Soy Isoflavones: Multiple-Dose Administration to Men with Prostate Neoplasia. Nutrition and Cancer. 48(2). 160–170. 81 indexed citations

15.

Huffman, John W., John R. Miller, John Liddle, et al.. (2003). Structure–activity relationships for 1′,1′-dimethylalkyl-Δ8-tetrahydrocannabinols. Bioorganic & Medicinal Chemistry. 11(7). 1397–1410. 29 indexed citations

16.

Hunt, Patricia A., Kara E. Koehler, Martha Susiarjo, et al.. (2003). Bisphenol A Exposure Causes Meiotic Aneuploidy in the Female Mouse. Current Biology. 13(7). 546–553. 466 indexed citations

17.

Busby, Marjorie G., A. Robert Jeffcoat, LeAnne T. Bloedon, et al.. (2002). Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. American Journal of Clinical Nutrition. 75(1). 126–136. 216 indexed citations

18.

Lever, John R., Ursula Scheffel, Marigo Stathis, et al.. (1996). Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3β-(4-[125I]iodophenyl) tropan-2β-carboxylic acid isopropyl ester ([125I]RTM-21). Nuclear Medicine and Biology. 23(3). 277–284. 18 indexed citations

19.

Thomas, Brian F., et al.. (1988). Modification of phencyclidine intoxification and biodisposition by charcoal and other treatments. Pharmacology Biochemistry and Behavior. 30(2). 371–377. 2 indexed citations

20.

Thomas, Brian F., Edward R. Bowman, Susan Tucker, & Mario D. Aceto. (1988). Plasma concentrations of nicotine in rats during tolerance and chronic exposure studies. European Journal of Drug Metabolism and Pharmacokinetics. 13(4). 247–252. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact